Prostate Cancer Research
Funding research to increase survival and find a cure for men with advanced prostate cancer
Research Projects
Research Projects

Our Research

We are proud to work with the UK’s top scientists with a shared aim of reducing morbidity, increasing survival rates and improving quality of life for men with prostate cancer.

We fund a diverse portfolio of projects at some of the UK’s leading institutions in prostate cancer, ranging from early-stage biological insights to drug development.
About us

Showing 20 Active Projects

A blood test to revolutionise early detection

Validating a new blood test that could transform the way we diagnose prostate cancer

£500,000 Starts: January 2024
University of Cambridge

Unlocking the power of sugars to revolutionise treatments for bone metastasis’

Targeting glycans to block prostate cancer spread

£498,765/year Starts: December 2023
Newcastle University and University of Leicester

Tackling therapeutic resistance in prostate cancer disparities

Reducing prostate cancer disparities by inhibiting cell signalling and growth.

$50,000 per year Starts: March 2023
Clark Atlanta University

Discovering genetic drivers of prostate cancer in Black men

Identifying race specific variants, pathways, and genes that drive prostate cancer risk in Black men compared to White men.

$49,999 per year Starts: March 2023
Baylor College of Medicine

Linking the immune system to prostate cancer disparities

Establishing the role of the immune system in racial disparities in prostate cancer

$80,000/year Starts: March 2023
Clark Atlanta University

Mapping differences in treatment patterns

£83,000 per year Starts: November 2022
University College London

Identifying Black men at increased risk of developing prostate cancer

Investigating genetic differences to predict the risk of prostate cancer.

£70,000 per year Starts: November 2022
University of Essex

Reducing barriers to screening in Black men with prostate cancer

Examining the links between neighbourhood factors, PSA testing and prostate cancer mortality

$130,000 per year Starts: October 2022
Dana-Farber Cancer Institute, Harvard

The epigenetic journey to prostate cancer

Investigating the epigenetic evolution of prostate cancer

£166,000/year Starts: October 2022
Newcastle University Centre for Cancer

Genetic test for prostate cancer in Black men

Developing a test to screen for prostate cancer

£84,000/year Starts: October 2022
University of East Anglia

Tackling barriers to early diagnosis

Early diagnosis of PROstate CANcer for Black men (PROCAN-B)

£79,000/year Starts: September 2022
University of Sunderland

MCL-1: A new therapy for prostate cancer?

77,000/year Starts: October 2021
Cancer Research UK Beatson Institute, Glasgow

Blocking prostate cancer signals

£164,000/year Starts: September 2021
Cardiff University

How fat fuels prostate cancer

Investigating the link between fat and prostate cancer

£160,000/year Starts: July 2021
Imperial College London

AI: Computing solutions for prostate cancer

Is your prostate cancer a tiger or a pussycat?

£110,000/year Starts: March 2020
University of East Anglia

Hormone Therapy: Old Dog, New Tricks

New approaches to hormone therapy to keep it working for longer

£130,000/year Starts: November 2019
University of Aberdeen

Hormone Therapy: Stopping resistance in its tracks

Investigating how prostate cancers become resistant to hormone therapy

£110,000/year Starts: January 2020
Newcastle University Centre for Cancer

Improving Radiotherapy

Combining radiotherapy with other drugs to improve patient outcomes

£136,000/year Starts: January 2020
University of Oxford

ProCASP: could damaging DNA cure my cancer?

Investigating why damaging the DNA inside cancer cells only works as a treatment for some prostate cancer patients

£100,000/year Starts: November 2020
University of Cambridge

STAMPEDE: which drug will work best for me?

Developing a test to choose treatment for individual patients

£136,000/year Starts: December 2020
UCL
Press enter or esc to cancel